CLSA Adds Substantial Depth To Board With Several New Appointments

New Members and Representation from Amgen, Ardelyx, Boehringer Ingelheim, Cortexyme, DuPont Nutrition & Biosciences, Ernst & Young, GRAIL, Medtronic and Nkarta Therapeutics

SAN FRANCISCO and SAN DIEGO, Calif. – August 20, 2019 – California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, today announced the appointment of several new members to CLSA’s Board of Directors. Joining the board are:

  • Victoria Blatter, Senior Vice President, U.S. Government Affairs, Amgen
  • Elizabeth Grammer, Executive Vice President, General Counsel and Head of Human Resources, Ardelyx, Inc.
  • Jennifer Johnson, Ph.D., Associate General Counsel, DuPont Nutrition & Biosciences
  • Casey Lynch, CEO, Co-founder, and Chairman, Cortexyme
  • Joshua Ofman, M.D., M.S.H.S., Chief of Corporate Strategy and External Affairs, GRAIL (Current Board Member Changing Affiliation to GRAIL)
  • Matthew Plunkett, Ph.D., Senior Vice President & Chief Financial Officer, Nkarta Therapeutics
  • Stacey Pugh, Vice President and General Manager, Neurovascular, Medtronic
  • Fran Schulz, Partner, Assurance Services – Life Sciences Practice, Ernst & Young
  • Bridget Walsh, Vice President, Government Affairs and Public Policy, Boehringer Ingelheim

More here: